Pharmafile Logo

03 Health Services

April 25, 2019 |  

How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation

The pharma market is about to get busy. 2011–2013 marks a patent cliff, when many big-selling drugs went, or soon will go, off patent. 2013–2015 promises several new products jostling for attention. This time the stakes are even higher than usual, and companies will need to get their new products firmly established to secure future revenues. They will also be launching into a fast-evolving digital ecosystem.

Specific products will offer different medical merits but their success will depend on how effectively brands can blend digital into their launch process — and how much value dynamic digital services add to the product offering. Many areas of healthcare have already been busy harnessing the potential of digital in innovative technical ways: gene sequencing, diagnostic imaging, telemedicine, electronic medical records, and so on.

Many believe that pharmaceutical marketing has been slow to find the relevance of digital innovation for standard consumer offerings, but the potential to capitalise on technology for health is limitless. Where entertainment and retail may offer services and interactions that people want, healthcare has the opportunity to create services that people need.

This content was provided by Havas Lynx

Documents for download:

Company Details

 Latest Content from  Havas Lynx 

Havas Lynx celebrates 40 years of impact

Starting out in 1986 as a team of two in Manchester’s Northern Quarter, Havas Lynx has much to celebrate, having grown to become an international healthcare communications agency with offices...

Doctored Truths

When the truth is doctored, lives hang in the balance.

Climate of Health

What’s happening to our planet is having an undeniable and devastating impact across every aspect of human health. What harms the world, harms us all. And these effects are so...

Passion and Pain: Millennial HCP Report

When we investigate millennial healthcare professionals (HCPs), we see a generation experiencing a clash of two existences. On one hand, harness their passion and it’s like bottling lightening.  On the other, a more sobering story...

Health for All

Stories matter. They bind people together, create a sense of connection, and engage our thoughts, emotions, and imagination all at once. They show us other people’s perspectives and let us...

Doctored Truths urges pharma to lead the fight against health misinformation

“Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row....

Havas Lynx Welcomes New Leadership Hires

Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.

Havas to Open New Manchester Village at Circle Square

The global communications group will unite six agencies under one roof in a purpose-built, hybrid workspace at the heart of Manchester’s innovation district

Havas Lynx launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx , has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

Healing the Healers

Because if we do not heal the healers, who is going to heal us?